Technological progress and the market value of firms

International Journal of Management Reviews

Volumn 1, Issue 4, 1999, Pages 485-501

  Brockhoff, Klaus K ^a  

^a WHU OTTO BEISHEIM SCHOOL OF MANAGEMENT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005223324     PISSN: 14608545     EISSN: None     Source Type: Journal    
DOI: 10.1111/1468-2370.00024     Document Type: Article

References (40)

1. Austin, D.H. (1993). An event-study approach to measuring innovative output: the case of biotechnology. American Economic Review, 83, 253-258.
2. Austin, D.H. (1995). The power of patents. Resources, No. 119, 2-5.
3. Capon, N., Farley, J.U. and Hoenig, S. (1990). Determinants of financial performance: a meta-analysis. Management Science, 36, 1143-1159.
4. Chan, S.H., Martin, J.D. and Kensinger, J.W. (1990). Corporate research and development expenditures and share value. Journal of Financial Economics, 26, 255-276.
5. Chaney, P.K. and Devinney, T.M. (1992). New product innovations and stock price performance. Journal of Business, Finance and Accounting, 19, 677-695.
6. Chaney, P.K., Devinney, T.M. and Winer, R.W. (1991). The impact of new product introductions on the market value of firms. Journal of Business, 64, 573-610.
7. Chancy, P.K. and Devinney, T.K. (1992). Who are the innovators and what do they gain? Working Paper, Owen Graduate School of Management, Vanderbilt University.
8. Chauvin, K.W. and Hirschey, M. (1993). Advertising, R&D expenditures and the market value of the firm. Financial Management, 22, 128-140.
9. Cockburn, I. and Griliches, Z. (1988). Industry effects and appropriability measures in the stock market's valuation of R&D and patents. American Economic Review, 78, 419-423.
10. Connolly, R.A. and Hirschey, M. (1984). R&D, market structure and profits, a value-based approach. Review of Economics and Statistics, 66, 682-686.
11. Connolly, R.A. and Hirschey, M. (1988). Market value and patents, a Bayesian approach. Economics Letters, 27, 83-87.
12. Demirag, I.S. (ed.) (1998a). Corporate Governance, Accountability, and the Pressures to Perform - An International Study. Stamford, CT, London: JAI Press.
13. Demirag, I.S. (1998b). Short-term performance pressures, corporate governance, and accountability: an overview. In Demirag, I.S. (ed.), Corporate Governance, Accountability, and the Pressures to Perform - An International Study. Stamford, CT, London: JAI Press, pp. 1-7.
14. Demirag, I.S. (1998c). Short termism, financial systems, and corporate governance: a theoretical framework. In Demirag, I.S. (ed.), Corporate Governance, Accountability, and the Pressures to Perform -An International Study. Stamford, CT, London: JAI Press, pp. 7-24.
15. Eddy, A.R. and Saunders, G.B. (1980). New product announcements and stock prices. Decision Sciences, 11, 90-97.
16. Eddy, A.R., Fletcher, H.D., Margenthaler, C.R. and Reinhart, W.J. (1993). Financial signaling and new product announcements. The Midatlantic Journal of Business, 29, 97-108.
17. General Electric (1994). Annual Report, 4.
18. Goodcare, A., Pratt, K.C., Thomas, R.E. and MacGrath, J. (1990). Perceptions of accounting disclosure of R&D expenditure: an experimental study. Cited in Demirag, I.S., Short terminism, financial systems, and corporate governance. Corporate Governance, Accountability, and the Pressures to Perform -An International Study. Stamford, CT, London: JAI Press, pp. 7-24.
19. Green, J.P., Andrew, W. and Thomas, H.M. (1996). UK evidence on the market valuation of research and development expenditures. Journal of Business Finance & Accounting, 23, 191-216.
20. Griliches, Z. (1981). Market value, R&D and patents. Economics Letters, 7, 183-187.
21. Griliches, Z., Hall, B.H. and Pakes, A. (1991). R&D, patents, and market value revisited: is there a second (technological opportunity) factor? Economics of Innovation and New Technology, 1, 183-201.
22. Hall, B.H. (1993). The stock market's valuation of R&D investment during the 1980's. American Economic Review, 83, 259-264.
23. Harhoff, D., Scherer, F.M. and Vopel, K. (1997). Exploring the tail of the patent value distributions. Mannheim, ZEW Working Paper 97-30.
24. Hendricks, K.B. and Singhal V.R. (1997). Delays in new product introductions and the market value of the firm: the consequences of being late to the market. Management Science, 43, 422-436.
25. Higson, C. (1996). Discussion of UK evidence on the market valuation of research and development. Journal of Business Finance & Accounting, 23, 217-219.
26. Jaffe, A.B. (1986). Technological opportunity and spillovers of R&D: evidence from firms' patents, profits, and market value. American Economic Review, 76, 984-1001.
27. Jarrell, G., Lehn, K. and Warr, W. (1985). Institutional Ownership, Tender Offers and Long-term Investments. Office of the Chief Economist, Securities and Exchange Commission, 19 April.
28. Kelm, K.M., Narayanan, V.K. and Pinches, G.E. (1995). The response of capital markets to the R&D process. Technological Forecasting and Social Change, 49, 75-88.
29. Magna, P. and Klock, M. (1993). The impact of intangible capital on Tobin's q in the semiconductor industry. American Economic Review, 83, 265-269.
30. McCutchen, W.W. Jr and Swamidass, P.M. (1996). Effect of R&D expenditures and funding strategies on the market value of biotech firms. Journal of Engineering and Technology Management, 12, 287-299.
31. Pakes, A. (1985). On patents, R&D, and the stock market rate of return. Journal of Political Economy, 93, 390-409.
32. Report (1998). Dax-Unternehmen im Urteil gehobener Zielgruppen. Absatzwirtschaft, Special Issue October, 90-95.
33. Schering AG (1994). Annual Report.
34. Schering AG (1995). Annual Report.
35. Schering AG (1996). Annual Report.
36. Schirm, K. (1995). Die Glaubwürdigkeit von Produkt-Vorankündigungen. Wiesbaden: DUV.
37. Schmidt, R. (1998). Financial markets, corporate governance, and short-term pressures in Germany. In Demirag, I.S. (ed.), Corporate Governance, Accountability, and Pressures to Perform - An International Study. Stamford, CT, London: JAI Press, pp. 297-332.
38. Suchy, H. (1992). Patentrestlaufzeit neuer pharmazeutischer Wirkstoffe. Gewerblicher Rechtschutz und Urheberrecht (GRUR), 94, 7-13.
39. Wittink, D., Ryans, A. and Burrus, N. (1982). New products and security prices. Working Paper, Cornell University, Ithaca, NY.
40. Woolbridge, J.R. and Snow, C.C. (1990). Stock market reaction to strategic investment decisions. Strategic Management Journal, 11, 353-363.